SecBot SecBot

LMRI

Lumexa Imaging Holdings, Inc.
Nasdaq· Services-Medical Laboratories· Inc. DE· CIK 0002071288 Healthcare & Medical Devices
$11.74 +0.08 (+0.69%)
Oct 26 4:00 PM ET · prev $11.66
Market cap
$1.0B
Small cap
Consensus
Buy
93% Buy or better · 15 analysts
Median target
$18.00
+53% · range $13.00–23.00
Since first trade
−36.6%
from $18.52 · Dec 11
30 days
+15.7%
from $10.15
Range since listing
$6.77–18.53
−37% from high · low May 18
Avg volume 20D
367.1K
shares / day
Short interest
2.02M
≈2.1% of shares · −4.8%
Days to cover
4.1
at average volume
Insider net
+$476.9K
2 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest NEUTRAL Lumexa Imaging reported Q2 2026 revenue of $264.2M (+5.1% YoY), beating consensus of $263.1M, and Adjusted…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $476.9K at an average $7.34. No open-market sales. Price is 60% above their cost.

  • InstitutionsMIXED

    Q2 2026: 16 added (0 new), 14 trimmed or exited.

  • AnalystsBULLISH

    14 of 15 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −4.8% to 2.02M shares. 4.1 days to cover, ≈2.1% of shares.

  • TrendUPTREND

    6% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BROWN ADVISORY INCDOUBLED5,777,574$65.2M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ADD3,453,723$39.0M
ROYCE & ASSOCIATES LPDOUBLED789,040$8.9M
Schonfeld Strategic Advisors LLCDOUBLED768,890$8.7M
ADAGE CAPITAL PARTNERS GP, L.L.C.ADD625,270$7.1M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDTRIM600,000$6.8M
Point72 Asset Management, L.P.DOUBLED280,963$3.2M
SEI INVESTMENTS CODOUBLED224,343$2.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 93% rate it Buy or better
Strong Buy6Buy8Hold1Sell0Strong Sell0
12-month targets · 9 analysts

Price is below the lowest target. Median implies +53%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 5, 2026Truist Securities
INITIATE
INITIATEBuy
Sep 25, 2026Keybanc
INITIATE
INITIATEOverweight
Aug 28, 2026Barclays
MAINTAIN
MAINTAINOverweight
May 20, 2026Barclays
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$476.9K
bought · 2 insiders
$0
sold · 0 insiders
+60.0%
vs their $7.34 cost
DateInsiderTypeValue
Jun 10, 2026
EISENBERG GLENN A
Director
AWARD19,358 sh
Jun 10, 2026
Joseph Molly
Director
AWARD19,358 sh
Jun 10, 2026
Cooper Henry Lee
Director
AWARD19,358 sh
Jun 10, 2026
Mittl Robert Louis Jr.
Director
AWARD19,358 sh
Jun 10, 2026
BRODNAX BRETT
Director
AWARD19,358 sh
Jun 10, 2026
Karlin Bridget E
Director
AWARD19,358 sh
Jun 10, 2026
Lungren Matthew
Director
AWARD19,358 sh
May 19, 2026
BRODNAX BRETT
Director
BUY$253.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
2,023,071
shares short
-4.8%
vs prior settlement
4.1
days to cover
≈2.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 SEC
Lumexa Imaging reported Q2 2026 revenue of $264.2M (+5.1% YoY), beating consensus of $263.1M, and Adjusted EPS of…
8-K — Impact 5/10
Aug 12, 2026 Earnings
Lumexa Imaging Announces Second Quarter 2026 Results
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s
Jun 30, 2026 SEC
Lumexa Imaging entered into Amendment No. 7 to its credit agreement, refinancing its existing $823M secured term loan…
8-K — Impact 4/10
Jun 30, 2026 Inst.
BROWN ADVISORY INC — DOUBLED
5,777,574 shares ($65.2M)
Jun 30, 2026 Inst.
MASSACHUSETTS FINANCIAL SERVICES CO — ADD
3,453,723 shares ($39.0M)
Jun 10, 2026 Insider
EISENBERG GLENN A was granted 19,358 shares
Director
Jun 10, 2026 Insider
Joseph Molly was granted 19,358 shares
Director
Jun 10, 2026 Insider
Cooper Henry Lee was granted 19,358 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 12, 2026
Earnings
Lumexa Imaging Announces Second Quarter 2026 Results
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging…
Aug 12, 2026
Earnings date
LMRI Q2 2026 Earnings Scheduled — 2026-08-12
Jul 29, 2026
Earnings
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging…
May 12, 2026
Earnings
Lumexa Imaging Announces First Quarter 2026 Results
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services…
May 12, 2026
Earnings date
LMRI Q1 2026 Earnings Scheduled — 2026-05-12

SecBot reports

4 filings · 0 bullish · 1 bearish · 3 neutral
All LMRI filing & press-release reports (4)